Riggins RB - Search Results

1

Trans-resveratrol boronic acid exhibits enhanced anti-proliferative activity on estrogen-dependent MCF-7 breast cancer cells.

Yenugonda VM, Kong Y, Deb TB, Yang Y, Riggins RB, Brown ML. Yenugonda VM, et al. Among authors: riggins rb. Cancer Biol Ther. 2012 Aug;13(10):925-34. doi: 10.4161/cbt.20845. Epub 2012 Aug 1. Cancer Biol Ther. 2012. PMID: 22785207 Free PMC article.

2

interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).

Bouker KB, Skaar TC, Fernandez DR, O'Brien KA, Riggins RB, Cao D, Clarke R. Bouker KB, et al. Among authors: riggins rb. Cancer Res. 2004 Jun 1;64(11):4030-9. doi: 10.1158/0008-5472.CAN-03-3602. Cancer Res. 2004. PMID: 15173018

3

The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.

Riggins RB, Zwart A, Nehra R, Clarke R. Riggins RB, et al. Mol Cancer Ther. 2005 Jan;4(1):33-41. Mol Cancer Ther. 2005. PMID: 15657351

4

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.

Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, Zwart A, Wang A, Clarke R. Bouker KB, et al. Among authors: riggins rb. Carcinogenesis. 2005 Sep;26(9):1527-35. doi: 10.1093/carcin/bgi113. Epub 2005 May 5. Carcinogenesis. 2005. PMID: 15878912

5

Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer.

Riggins RB, Bouton AH, Liu MC, Clarke R. Riggins RB, et al. Vitam Horm. 2005;71:201-37. doi: 10.1016/S0083-6729(05)71007-4. Vitam Horm. 2005. PMID: 16112269 Review.

6

Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines.

Gomez BP, Riggins RB, Shajahan AN, Klimach U, Wang A, Crawford AC, Zhu Y, Zwart A, Wang M, Clarke R. Gomez BP, et al. Among authors: riggins rb. FASEB J. 2007 Dec;21(14):4013-27. doi: 10.1096/fj.06-7990com. Epub 2007 Jul 27. FASEB J. 2007. PMID: 17660348

7

ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.

Riggins RB, Lan JP, Zhu Y, Klimach U, Zwart A, Cavalli LR, Haddad BR, Chen L, Gong T, Xuan J, Ethier SP, Clarke R. Riggins RB, et al. Cancer Res. 2008 Nov 1;68(21):8908-17. doi: 10.1158/0008-5472.CAN-08-2669. Cancer Res. 2008. PMID: 18974135 Free PMC article.

8

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Clarke R, Shajahan AN, Riggins RB, Cho Y, Crawford A, Xuan J, Wang Y, Zwart A, Nehra R, Liu MC. Clarke R, et al. Among authors: riggins rb. J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):8-20. doi: 10.1016/j.jsbmb.2008.12.023. J Steroid Biochem Mol Biol. 2009. PMID: 19444933 Free PMC article.

9

BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.

Nehra R, Riggins RB, Shajahan AN, Zwart A, Crawford AC, Clarke R. Nehra R, et al. Among authors: riggins rb. FASEB J. 2010 Jun;24(6):2040-55. doi: 10.1096/fj.09-138305. Epub 2010 Feb 12. FASEB J. 2010. PMID: 20154269 Free PMC article.

10

IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.

Ning Y, Riggins RB, Mulla JE, Chung H, Zwart A, Clarke R. Ning Y, et al. Among authors: riggins rb. Mol Cancer Ther. 2010 May;9(5):1274-85. doi: 10.1158/1535-7163.MCT-09-1169. Mol Cancer Ther. 2010. PMID: 20457620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters